Hamlet Pharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in Lund.

Quotes for Hamlet Pharma AB

Right Now

+/-
-0.3
%
-0,67%
Latest
44.7
High
44.8
Low
42.8
Volume
20 386
Turnover (SEK)
897 434
Value (MSEK)
1 413,6

Board

CEO

  • Mats Persson

Chairman Of The Board

  • Catharina Svanborg

Board

  • Bengt Westermark
  • Christer Köhler
  • Helena Lomberg

Videos

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 53,36 53,36 2019-06-30
Avanza Pension 4,54 4,54 2019-06-30
Nordnet Pensionsförsäkring 4,13 4,13 2019-06-30
FV Group AB 1,90 1,90 2019-06-30
Hans Nygren 1,74 1,74 2019-06-30
Fredrik Herslow 1,58 1,58 2019-06-30
Livförsäkringsbolaget Skandia 0,81 0,81 2019-06-30
Creative Invest One AB 0,45 0,45 2019-06-30
Olle Jönsson 0,43 0,43 2019-06-30
Arne Hjortsberg 0,32 0,32 2019-06-30
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2019-11-08 Delårsrapport 2020-Q1

  • 2019-11-21 Årsstämma 2019